Buried in a U.S. Senate proposal to end the federal government shutdown was a small provision that will make a big difference to those worried about PAMA cuts to clinical labs.
On November 10, the Senate amended and passed a version of a bill from the Hou... See more
Regulatory uncertainty. Revenue pressure. Technology decisions. These three trends for 2026 point to outside forces squeezing clinical laboratory managers, but optimists are hoping for at least a sprinkling of relief.
Medical laboratories should expect co... See more
